Celldex Therapeutics, Inc.

NASDAQ: CLDX
$12.94
+$0.83 (+6.9%)
Closing price September 18, 2020
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February and March.
Ambev, Renren, Celldex, and Yatra Online all posted new 52-week lows Friday.
General Electric, Starbucks, General Dynamics, and Celldex all posted new 52-week lows Thursday.
Oracle, Starbucks, Helios and Matheson, and Celldex all posted new 52-week lows Wednesday.
Banco Bradesco, Gogo, Tesaro, and Celldex all posted new 52-week lows Wednesday.
J.C. Penney, Helios and Matheson, Celldex, and Spectra Energy Partners all posted new 52-week lows Tuesday.
MGIC Investment Group, Celldex Therapeutics, Juniper Networks, and Healthcare Services Group all posted new 52-week lows on Wednesday.
Celldex Therapeutics, Acacia Communications, Apricus Biosciences, and Ctrp.com all posted new 52-week lows Monday.
Celldex Therapeutics shares were absolutely crushed on Monday morning after the firm announced results to its midstage breast cancer study.
Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock moves. Some stocks have the potential to double or even crater, should a study be...
The top analyst upgrades, downgrades and other research calls include American Airlines, Boeing, Cabot Oil & Gas, Pandora Media, Southern Co. and Vertex Pharmaceuticals.
Macy's, Tegna, Celldex, and DryShips posted new 52-week lows Tuesday.
Celldex Therapeutics was another big mover coming out of the Annual Meeting for the American Society of Clinical Oncology (ASCO). Unfortunately, the move was to the downside.
24/7 Wall St. has collected several big FDA decisions and mid-stage to late-stage trials that should be announced in October.
24/7 Wall St. has collected several big FDA decisions and mid- to late-stage trials that should be coming up in late-September and October.